Rock Weekly: AMZN and GOOG compete to control your genome

June 8, 2015 Digital health kicked off the month of June with its third IPO of 2015: Evolent Health, which earned

Rock Weekly: Death to the EHR?

June 1, 2015 What takes up 50% more of a doctor's time than caring for patients, was supposed to save $77B for ...

Rock Weekly: Should the brain be treated as a medical device?

May 26, 2015 Let’s talk about robots. They’re hyper-accurate, cost-saving, depression-diagnosing—even cute. ...

Insights from digital health’s most active investors

Last Friday we co-hosted the third annual Digital Health Investor Summit with Fenwick and West to a packed audience

Rock Weekly: Which digital health companies will IPO in 2015?

May 18, 2015 Another week, another $100M digital health IPO filing—this time, Mindbody. On that topic, we polled ...

Non-healthcare acquirers heating up digital health M&A activity

The trend of non-traditional players investing in digital health indicates that healthcare is no longer a silo as these players identify value of incorporating healthcare into their business model. The growth of consumers willing to pay out of pocket for healthcare-related expenses, whether that’s medical or wellness-oriented, is creating an attractive market for B2C models.

Deconstructing the Fitbit IPO and S-1

Fitbit is the latest iconic digital health company planning to IPO, with a drastically different operating history ...

Rock Weekly: Deconstructing the Fitbit IPO

May 11, 2015 Digital health IPOs are finally heating up. Off the heels of another filing last week, ...

Meet the founder who is redefining chronic care management

Update: In July, 2015, Welkin Health closed their $2M seed round, with participation from Rock Health, Asset ...

Rock Weekly: What do IBM, Apple, and UHC have in common?

May 4, 2015 What do IBM, Apple, and UnitedHealthcare have in common? They're all avid fans of the shifting center ...

Join our mailing list.

The most popular digital health newsletter. Subscribe to the Rock Weekly to be the first to know about our newest reports.